» Articles » PMID: 26378466

Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass

Overview
Journal Mol Endocrinol
Date 2015 Sep 18
PMID 26378466
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Loss of pancreas β-cell function is the precipitating factor in all forms of diabetes. Cell replacement therapies, such as islet transplantation, remain the best hope for a cure; however, widespread implementation of this method is hampered by availability of donor tissue. Thus, strategies that expand functional β-cell mass are crucial for widespread usage in diabetes cell replacement therapy. Here, we investigate the regulation of the Hippo-target protein, Yes-associated protein (Yap), during development of the endocrine pancreas and its function after reactivation in human cadaveric islets. Our results demonstrate that Yap expression is extinguished at the mRNA level after neurogenin-3-dependent specification of the pancreas endocrine lineage, correlating with proliferation decreases in these cells. Interestingly, when a constitutively active form of Yap was expressed in human cadaver islets robust increases in proliferation were noted within insulin-producing β-cells. Importantly, proliferation in these cells occurs without negatively affecting β-cell differentiation or functional status. Finally, we show that the proproliferative mammalian target of rapamycin pathway is activated after Yap expression, providing at least one explanation for the observed increases in β-cell proliferation. Together, these results provide a foundation for manipulating Yap activity as a novel approach to expand functional islet mass for diabetes regenerative therapy.

Citing Articles

Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1: A Potential Compound to Improve Spermatogenesis in Mouse Model of Diabetes Mellitus.

Amanda B, Faizah Z, Pakpahan C, Aziz M, Hamidah B, Ashari F Biomedicines. 2024; 12(11).

PMID: 39595079 PMC: 11591716. DOI: 10.3390/biomedicines12112513.


Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation.

Wu Y, Qin K, Xu Y, Rajhans S, Vo T, Lopez K Elife. 2024; 13.

PMID: 39051998 PMC: 11272159. DOI: 10.7554/eLife.84532.


Regulation of autophagy by perilysosomal calcium: a new player in β-cell lipotoxicity.

Nguyen H, Wiederkehr A, Wollheim C, Park K Exp Mol Med. 2024; 56(2):273-288.

PMID: 38297165 PMC: 10907728. DOI: 10.1038/s12276-024-01161-x.


VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation.

Li F, Liu R, Negi V, Yang P, Lee J, Jagannathan R Cell Rep. 2023; 42(1):111904.

PMID: 36662616 PMC: 9970006. DOI: 10.1016/j.celrep.2022.111904.


TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism.

Li F, Negi V, Yang P, Lee J, Ma K, Moulik M Nucleic Acids Res. 2022; 50(22):12723-12738.

PMID: 36484096 PMC: 9825168. DOI: 10.1093/nar/gkac1063.


References
1.
Miyatsuka T, Kosaka Y, Kim H, German M . Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a. Proc Natl Acad Sci U S A. 2010; 108(1):185-90. PMC: 3017196. DOI: 10.1073/pnas.1004842108. View

2.
Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M . YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis. 2010; 32(3):389-98. DOI: 10.1093/carcin/bgq254. View

3.
Karslioglu E, Kleinberger J, Salim F, Cox A, Takane K, Scott D . cMyc is a principal upstream driver of beta-cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta-cell replication. Mol Endocrinol. 2011; 25(10):1760-72. PMC: 3182418. DOI: 10.1210/me.2011-1074. View

4.
Chen H, Gu X, Liu Y, Wang J, Wirt S, Bottino R . PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature. 2011; 478(7369):349-55. PMC: 3503246. DOI: 10.1038/nature10502. View

5.
Zhang H, Deo M, Thompson R, Uhler M, Turner D . Negative regulation of Yap during neuronal differentiation. Dev Biol. 2011; 361(1):103-15. PMC: 3235039. DOI: 10.1016/j.ydbio.2011.10.017. View